Chemomab Therapeutics (CMMB) Cash from Operations (QoQ) (2018 - 2023)
Chemomab Therapeutics (CMMB) Cash from Operations (QoQ) (2018 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Chemomab Therapeutics | 124.14 Mn | 113.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 28.82% |
| Sep 30, 2023 | 30.24% |
| Jun 30, 2023 | -4.17% |
| Mar 31, 2023 | -26.00% |
| Dec 31, 2022 | -8.53% |
| Sep 30, 2022 | 7.82% |
| Jun 30, 2022 | -53.62% |
| Mar 31, 2022 | -28.23% |
| Dec 31, 2021 | -12.17% |
| Sep 30, 2021 | 53.99% |
| Jun 30, 2021 | -333.64% |
| Mar 31, 2021 | 16.85% |
| Dec 31, 2020 | -72.59% |
| Sep 30, 2020 | -3.21% |
| Jun 30, 2020 | 54.36% |
| Mar 31, 2020 | 67.65% |
| Dec 31, 2019 | -68.63% |
| Sep 30, 2019 | 10.42% |
| Jun 30, 2019 | -25.40% |
| Mar 31, 2019 | 11.33% |